Pegylated (40 kDa) interferon alfa-2a (PEGASYS®) in combination with Ribavirin, mycophenolate motelil (CellCept®), amantadine, or amantadine plus ribavirin in patients that relapsed on rebetronTM therapy: A preliminary report of a randomized, multicenter efficacy and safety study

2001 ◽  
Vol 120 (5) ◽  
pp. A384-A384 ◽  
Author(s):  
S HERRINE ◽  
R BROWNJR ◽  
S ESPOSITO ◽  
A LOK ◽  
J GALATI ◽  
...  
Keyword(s):  
Preliminary Report ◽  
Interferon Alfa ◽  
Efficacy And Safety ◽  
Safety Study

Pegylated (40 KDA) interferon alfa-2a (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study

2001 ◽  
Vol 34 ◽  
pp. 143 ◽  
Author(s):  
A.M. Di Bisceglie ◽  
D.E. Bernstein ◽  
V.R. Rustgi ◽  
N. Gitlin ◽  
L.J. Jeffers ◽  
...  
Keyword(s):  
Interferon Alfa ◽  
New Combination ◽  
Efficacy And Safety ◽  
Combination Therapies ◽  
Safety Study
Sign in / Sign up

Export Citation Format

Share Document